These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34731633)

  • 1. Inherent genomic properties underlie the epigenomic heterogeneity of human induced pluripotent stem cells.
    Yokobayashi S; Yabuta Y; Nakagawa M; Okita K; Hu B; Murase Y; Nakamura T; Bourque G; Majewski J; Yamamoto T; Saitou M
    Cell Rep; 2021 Nov; 37(5):109909. PubMed ID: 34731633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture.
    Geens M; Seriola A; Barbé L; Santalo J; Veiga A; Dée K; Van Haute L; Sermon K; Spits C
    Mol Hum Reprod; 2016 Apr; 22(4):285-98. PubMed ID: 26786180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erosion of X Chromosome Inactivation in Human Pluripotent Cells Initiates with XACT Coating and Depends on a Specific Heterochromatin Landscape.
    Vallot C; Ouimette JF; Makhlouf M; Féraud O; Pontis J; Côme J; Martinat C; Bennaceur-Griscelli A; Lalande M; Rougeulle C
    Cell Stem Cell; 2015 May; 16(5):533-46. PubMed ID: 25921272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
    Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
    Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.
    Ruiz S; Diep D; Gore A; Panopoulos AD; Montserrat N; Plongthongkum N; Kumar S; Fung HL; Giorgetti A; Bilic J; Batchelder EM; Zaehres H; Kan NG; Schöler HR; Mercola M; Zhang K; Izpisua Belmonte JC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16196-201. PubMed ID: 22991473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-chromosome inactivation in human iPSCs provides insight into X-regulated gene expression in autosomes.
    Topa H; Benoit-Pilven C; Tukiainen T; Pietiläinen O
    Genome Biol; 2024 May; 25(1):144. PubMed ID: 38822397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of pluripotency and differentiation.
    Boland MJ; Nazor KL; Loring JF
    Circ Res; 2014 Jul; 115(2):311-24. PubMed ID: 24989490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential X Chromosome Inactivation Patterns during the Propagation of Human Induced Pluripotent Stem Cells.
    Andoh-Noda T; Akamatsu W; Miyake K; Kobayashi T; Ohyama M; Kurosawa H; Kubota T; Okano H
    Keio J Med; 2017 Mar; 66(1):1-8. PubMed ID: 28111378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-specific CpG 'beacons' identify human-specific prefrontal cortex H3K4me3 chromatin peaks.
    Bell CG; Wilson GA; Beck S
    Epigenomics; 2014 Feb; 6(1):21-31. PubMed ID: 24579944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostaining of modified histones defines high-level features of the human metaphase epigenome.
    Terrenoire E; McRonald F; Halsall JA; Page P; Illingworth RS; Taylor AM; Davison V; O'Neill LP; Turner BM
    Genome Biol; 2010; 11(11):R110. PubMed ID: 21078160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epigenome in pluripotency and differentiation.
    Thiagarajan RD; Morey R; Laurent LC
    Epigenomics; 2014 Feb; 6(1):121-37. PubMed ID: 24579950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial partitioning of the regulatory landscape of the X-inactivation centre.
    Nora EP; Lajoie BR; Schulz EG; Giorgetti L; Okamoto I; Servant N; Piolot T; van Berkum NL; Meisig J; Sedat J; Gribnau J; Barillot E; Blüthgen N; Dekker J; Heard E
    Nature; 2012 Apr; 485(7398):381-5. PubMed ID: 22495304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
    Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
    Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal clustering of the epigenome reveals rules of dynamic gene regulation.
    Yu P; Xiao S; Xin X; Song CX; Huang W; McDee D; Tanaka T; Wang T; He C; Zhong S
    Genome Res; 2013 Feb; 23(2):352-64. PubMed ID: 23033340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erosion of dosage compensation impacts human iPSC disease modeling.
    Mekhoubad S; Bock C; de Boer AS; Kiskinis E; Meissner A; Eggan K
    Cell Stem Cell; 2012 May; 10(5):595-609. PubMed ID: 22560080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X chromosome inactivation in human pluripotent stem cells as a model for human development: back to the drawing board?
    Geens M; Chuva De Sousa Lopes SM
    Hum Reprod Update; 2017 Sep; 23(5):520-532. PubMed ID: 28582519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of novel human ground state naive pluripotent stem cells.
    Gafni O; Weinberger L; Mansour AA; Manor YS; Chomsky E; Ben-Yosef D; Kalma Y; Viukov S; Maza I; Zviran A; Rais Y; Shipony Z; Mukamel Z; Krupalnik V; Zerbib M; Geula S; Caspi I; Schneir D; Shwartz T; Gilad S; Amann-Zalcenstein D; Benjamin S; Amit I; Tanay A; Massarwa R; Novershtern N; Hanna JH
    Nature; 2013 Dec; 504(7479):282-6. PubMed ID: 24172903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Characterization of X Chromosome Inactivation in Human Pluripotent Stem Cells.
    Bar S; Seaton LR; Weissbein U; Eldar-Geva T; Benvenisty N
    Cell Rep; 2019 Apr; 27(1):20-29.e3. PubMed ID: 30943402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells.
    Hawkins RD; Hon GC; Lee LK; Ngo Q; Lister R; Pelizzola M; Edsall LE; Kuan S; Luu Y; Klugman S; Antosiewicz-Bourget J; Ye Z; Espinoza C; Agarwahl S; Shen L; Ruotti V; Wang W; Stewart R; Thomson JA; Ecker JR; Ren B
    Cell Stem Cell; 2010 May; 6(5):479-91. PubMed ID: 20452322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG Islands Shape the Epigenome Landscape.
    Papin C; Le Gras S; Ibrahim A; Salem H; Karimi MM; Stoll I; Ugrinova I; Schröder M; Fontaine-Pelletier E; Omran Z; Bronner C; Dimitrov S; Hamiche A
    J Mol Biol; 2021 Mar; 433(6):166659. PubMed ID: 33010306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.